Invention Grant
- Patent Title: Isolating method for umbilical cord blood-derived pluripotent stem cells expressing ZNF281
-
Application No.: US13257961Application Date: 2010-03-03
-
Publication No.: US10584312B2Publication Date: 2020-03-10
- Inventor: Kyung Sun Kang , Kyoung Hwan Roh
- Applicant: Kyung Sun Kang , Kyoung Hwan Roh
- Applicant Address: KR Seoul
- Assignee: SNU R&DB FOUNDATION
- Current Assignee: SNU R&DB FOUNDATION
- Current Assignee Address: KR Seoul
- Agency: Cooley LLP
- Priority: KR10-2009-0023821 20090320
- International Application: PCT/KR2010/001338 WO 20100303
- International Announcement: WO2010/107192 WO 20100923
- Main IPC: C12N5/0789
- IPC: C12N5/0789 ; A61K35/12 ; A61K35/44 ; C12N5/073

Abstract:
The present invention relates to a method for isolating pluripotent/multipotent stem cells derived from umbilical cord blood, characterized by culturing mononuclear cells isolated from umbilical cord blood in a culture vessel containing fibronectin and then harvesting stem cells from the culture, the umbilical cord blood-derived pluripotent/multipotent stem cells isolated thereby; and a cell therapeutic agent containing the pluripotent/multipotent stem cells derived from umbilical cord blood or cells differentiated therefrom. The present invention also relates to a novel culture media for stem cells, a culture method for stem cells which is characterized by culturing and proliferating stem cells in the culture media, and a method for increasing sternness of stem cells which is characterized by a sphere culture or a three-dimensional culture of stem cells.
Public/Granted literature
- US20120021509A1 ISOLATING METHOD FOR UMBILICAL CORD BLOOD-DERIVED PLURIPOTENT STEM CELLS EXPRESSING ZNF281 Public/Granted day:2012-01-26
Information query